GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » EV-to-Revenue

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) EV-to-Revenue : (As of May. 20, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Oracle Healthcare Acquisition's enterprise value is $0.00 Mil. Oracle Healthcare Acquisition's Revenue for the trailing twelve months (TTM) ended in Dec. 2007 was $0.00 Mil. Therefore, Oracle Healthcare Acquisition's EV-to-Revenue for today is .

The historical rank and industry rank for Oracle Healthcare Acquisition's EV-to-Revenue or its related term are showing as below:

OHAQ's EV-to-Revenue is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.85
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-20), Oracle Healthcare Acquisition's stock price is $0.0001. Oracle Healthcare Acquisition's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2007 was $0.00. Therefore, Oracle Healthcare Acquisition's PS Ratio for today is .


Oracle Healthcare Acquisition EV-to-Revenue Historical Data

The historical data trend for Oracle Healthcare Acquisition's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oracle Healthcare Acquisition EV-to-Revenue Chart

Oracle Healthcare Acquisition Annual Data
Trend Dec05 Dec06 Dec07
EV-to-Revenue
- 29.90 28.67

Oracle Healthcare Acquisition Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
EV-to-Revenue Get a 7-Day Free Trial 29.90 - - - 28.67

Competitive Comparison of Oracle Healthcare Acquisition's EV-to-Revenue

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oracle Healthcare Acquisition's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's EV-to-Revenue falls into.



Oracle Healthcare Acquisition EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Oracle Healthcare Acquisition's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/0
=

Oracle Healthcare Acquisition's current Enterprise Value is $0.00 Mil.
Oracle Healthcare Acquisition's Revenue for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oracle Healthcare Acquisition  (OTCPK:OHAQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Oracle Healthcare Acquisition's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0001/0
=

Oracle Healthcare Acquisition's share price for today is $0.0001.
Oracle Healthcare Acquisition's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oracle Healthcare Acquisition EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
Website
Executives
Andrew M Weiss 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc. 10 percent owner 500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc 10 percent owner 51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman 10 percent owner 7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c. 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg director C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg director, 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson director 12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik officer: CFO & Secretary
Joel D Liffman director, officer: President and COO C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines